Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;289(3):434-436.
doi: 10.1111/joim.13162. Epub 2020 Aug 18.

Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study

J Eimer  1 , J Vesterbacka  1 , A-K Svensson  1 , B Stojanovic  1 , C Wagrell  1 , A Sönnerborg  1   2 , P Nowak  1   2   3
Affiliations

Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study

J Eimer et al. J Intern Med. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors: No reported conflicts of interest.

Figures

Fig. 1
Fig. 1
Upper panel: Cumulative 30‐day survival rate depicted as Kaplan–Meier plots in the native (a) and propensity score matched cohort (b). Central panel: Cumulative rate of freedom from mechanical ventilation amongst invasively ventilated patients depicted as Kaplan–Meier plots in the native (c) and propensity score matched cohort (d). Lower panel: Total length of hospital stay, calculated from admission to the hospital until discharged alive or alive at 30 days in the (e) native cohort and (f) propensity score‐matched cohort. [Correction added on 19 October 2020, after first online publication: Figure 1 caption has been corrected in this current version.]
See this image and copyright information in PMC

References

    1. Grasselli G, Zangrillo A, Zanella A et al. Baseline characteristics and outcomes of 1591 patients infected With SARS‐CoV‐2 admitted to ICUs of the lombardy region. Italy. JAMA 2020; 323: 1574–81. - PMC - PubMed
    1. Mo X, Jian W, Su Z et al. Abnormal pulmonary function in COVID‐19 patients at time of hospital discharge. Eur Res J [Internet]. 2020. Jan 1 [cited 2020 Jun 5]. https://erj.ersjournals.com/content/early/2020/05/07/13993003.01217‐2020. - PMC - PubMed
    1. Blanco‐Melo D, Nilsson‐Payant BE, Liu W‐C et al. Imbalanced host response to SARS‐CoV‐2 drives development of COVID‐19. Cell 2020; 181: 1036–1045.e9. - PMC - PubMed
    1. Capra R, De Rossi N, Mattioli F et al. Impact of low dose tocilizumab on mortality rate in patients with COVID‐19 related pneumonia. Eur J Intern Med. 2020; 76: 31–5. - PMC - PubMed
    1. Xu X, Han M, Li T et al. Effective treatment of severe COVID‐19 patients with tocilizumab. Proc Natl Acad Sci USA 2020; 117: 10970–5. - PMC - PubMed

Substances